Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Interest Expenses (2016 - 2024)

Lifecore Biomedical, Inc. \De\ has reported Interest Expenses over the past 15 years, most recently at $4.6 million for Q4 2024.

  • Quarterly results put Interest Expenses at $4.6 million for Q4 2024, up 42.64% from a year ago — trailing twelve months through May 2025 was $5.6 million (down 74.37% YoY), and the annual figure for FY2024 was $14.7 million, up 4065.34%.
  • Interest Expenses for Q4 2024 was $4.6 million at Lifecore Biomedical, Inc. \De\, up from $983000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for LFCR hit a ceiling of $16.8 million in Q2 2022 and a floor of -$11.3 million in Q2 2023.
  • Median Interest Expenses over the past 5 years was $3.2 million (2022), compared with a mean of $3.3 million.
  • Biggest five-year swings in Interest Expenses: tumbled 192.53% in 2020 and later surged 439.36% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Interest Expenses stood at $1.6 million in 2020, then skyrocketed by 73.37% to $2.8 million in 2021, then skyrocketed by 30.39% to $3.6 million in 2022, then fell by 10.17% to $3.2 million in 2023, then soared by 42.64% to $4.6 million in 2024.
  • The last three reported values for Interest Expenses were $4.6 million (Q4 2024), $983000.0 (Q3 2024), and $12.1 million (Q2 2024) per Business Quant data.